<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id>
      <journal-title>BMC Infectious Diseases</journal-title>
      <issn pub-type="epub">1471-2334</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">17194310</article-id>
      <article-id pub-id-type="pmc">1780062</article-id>
      <article-id pub-id-type="publisher-id">1471-2334-6-179</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2334-6-179</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Case report: Infective endocarditis caused by <italic>Brevundimonas vesicularis</italic></article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Mei-Li</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>940424@ms.kmuh.org.tw</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Yen-Hsu</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>d810070@cc.kmu.edu.tw</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Tun-Chieh</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>dalechen.chen@gmail.com</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>Wei-Ru</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>940268@ms.kmuh.org.tw</email>
        </contrib>
        <contrib id="A5" contrib-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>Chun-Yu</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>infectionman@gmail.com</email>
        </contrib>
        <contrib id="A6" corresp="yes" contrib-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>Po-Liang</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>d830166@cc.kmu.edu.tw</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Internal Medicine, Kaohsiung Medical University Hospital, Taiwan</aff>
      <aff id="I2"><label>2</label>Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Taiwan</aff>
      <aff id="I3"><label>3</label>Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan</aff>
      <pub-date pub-type="collection">
        <year>2006</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>12</month>
        <year>2006</year>
      </pub-date>
      <volume>6</volume>
      <fpage>179</fpage>
      <lpage>179</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2334/6/179"/>
      <history>
        <date date-type="received">
          <day>7</day>
          <month>9</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>12</month>
          <year>2006</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2006 Yang et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2006</copyright-year>
        <copyright-holder>Yang et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Yang
               Mei-Li
               
               940424@ms.kmuh.org.tw
            </dc:author><dc:title>
            Case report: Infective endocarditis caused by Brevundimonas vesicularis
         </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>BMC Infectious Diseases 6(1): 179-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2334(2006)6:1&#x0003c;179&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2334</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>There are few reports in the literature of invasive infection caused by <italic>Brevundimonas vesicularis </italic>in patients without immunosuppression or other predisposing factors. The choice of antimicrobial therapy for bacteremia caused by the pathogen requires more case experience to be determined.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>The case of a 40-year-old previously healthy man with subacute endocarditis proposed to be contributed from an occult dental abscess is described. The infection was found to be caused by <italic>B. vesicularis </italic>on blood culture results. The patient recovered without sequelae after treatment with ceftriaxone followed by subsequent ciprofloxacin therapy owing to an allergic reaction to ceftriaxone and treatment failure with ampicillin/sulbactam.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>To our knowledge, this is the first report of <italic>B. vesicularis </italic>as a cause of infective endocarditis. According to an overview of the literature and our experience, we suggest that third-generation cephalosporins, piperacillin/tazobactam, and ciprofloxacin are effective in treating invasive <italic>B. vesicularis </italic>infections, while the efficacy of ampicillin-sulbactam needs further evaluation.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p><italic>Brevundimonas </italic>(formerly <italic>Pseudomonas</italic>) <italic>vesicularis </italic>is an aerobic nonsporulating and nonfermenting gram-negative bacillus [<xref ref-type="bibr" rid="B1">1</xref>] that has been isolated from the external environment [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B5">5</xref>] and human clinical specimens [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B15">15</xref>]. There have been only eight descriptions of infections in human beings caused by the microorganism, with only four cases of bacteremia reported in the literature [Table <xref ref-type="table" rid="T1">1</xref>, [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B15">15</xref>]]. Five cases of <italic>B. vesicularis </italic>infection were attributed to community sources [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B15">15</xref>] and three to nosocomial sources [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B11">11</xref>]. Such underlying diseases as autoimmune disorders associated with long-term steroid use, end-stage renal disease treated by hemodialysis, and sickle cell anemia with functional asplenia contributed to <italic>B. vesicularis </italic>infections in 6 of the 8 reported cases due to the patients' immunocompromised state [Table <xref ref-type="table" rid="T1">1</xref>, [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B15">15</xref>]]. <italic>B. vesicularis </italic>infection has therefore been classified as opportunistic [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. We report here a case of infective endocarditis caused by <italic>B. vesicularis </italic>in a patient without comorbid disease. The low number of cases reported of <italic>B. vesicularis </italic>infection in humans limits the body of knowledge on the spectrum of disease caused by this pathogen as well as optimal treatment regimens. The treatment course of the current case and previous cases of <italic>B. vesicularis </italic>infection is further discussed.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Summary of reported cases of <italic>Brevundimonas vesicularis </italic>infection in humans</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td align="left">
                <bold>Reference</bold>
              </td>
              <td align="left">
                <bold>Age (y)/sex</bold>
              </td>
              <td align="left">
                <bold>Underlying disease</bold>
              </td>
              <td align="left">
                <bold>Clinical presentation</bold>
              </td>
              <td align="left">
                <bold>Treatment/duration</bold>
              </td>
              <td align="left">
                <bold>Outcome</bold>
              </td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">(8)/NI</td>
              <td align="left">54/F</td>
              <td align="left">SLE, autoimmune hepatitis, steroid therapy</td>
              <td align="left">Necrotizing cellulitis</td>
              <td align="left">Tobramycin + ceftazidime/30d</td>
              <td align="left">Survival</td>
            </tr>
            <tr>
              <td align="left">(9)/NI</td>
              <td align="left">42/F</td>
              <td align="left">Mitral valve stenosis s/p mitral valve replacement</td>
              <td align="left">Septicaemia</td>
              <td align="left">Piperacillin - tazobactam/14d</td>
              <td align="left">Survival</td>
            </tr>
            <tr>
              <td align="left">(10)/CA</td>
              <td align="left">5/M</td>
              <td align="left">Sickle cell anemia</td>
              <td align="left">Pneumonia</td>
              <td align="left">Ceftriaxone + gentamicin/10d</td>
              <td align="left">Survival</td>
            </tr>
            <tr>
              <td align="left">(11)/NI</td>
              <td align="left">59&#x2013;67/both</td>
              <td align="left">Hemodialysis</td>
              <td align="left">Septicaemia</td>
              <td align="left">Cefotaxime + tobramycin/unknown</td>
              <td align="left">Survival</td>
            </tr>
            <tr>
              <td align="left">(12)/CA</td>
              <td align="left">60/M</td>
              <td align="left">Trauma</td>
              <td align="left">Botryomycosis</td>
              <td align="left">Cefuroxime- axetil/4 months</td>
              <td align="left">Survival</td>
            </tr>
            <tr>
              <td align="left">(13)/CA</td>
              <td align="left">38/M</td>
              <td align="left">No</td>
              <td align="left">Acute tonsillitis</td>
              <td align="left">amoxicillin- clavulanate/3d</td>
              <td align="left">Survival</td>
            </tr>
            <tr>
              <td align="left">(14)/CA</td>
              <td align="left">1.25/F</td>
              <td align="left">No</td>
              <td align="left">Septic arthritis</td>
              <td align="left">cefuroxime/12d + oral cephalexin/14d</td>
              <td align="left">Survival</td>
            </tr>
            <tr>
              <td align="left">(15)/CA</td>
              <td align="left">55/M</td>
              <td align="left">Continuous ambulatory peritoneal dialysis</td>
              <td align="left">peritonitis</td>
              <td align="left">ceftazidime/3d, ceftazidime + vancomycin/4d, ciprofloxacin + aztreonam/14d</td>
              <td align="left">Survival</td>
            </tr>
            <tr>
              <td align="left">current case/CA</td>
              <td align="left">40/M</td>
              <td align="left">No</td>
              <td align="left">Subacute endocarditis</td>
              <td align="left">cefazolin + gentamicin/3 d, Ampicillin/sulbactam + gentamicin/5 d, Ceftriaxone + gentamicin/7 d, ciprofloxacin/30 d</td>
              <td align="left">Survival</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>Abbreviations:</p>
          <p>CA = community-acquired infection;</p>
          <p>NI: nosocomial infection. Nosocomial infections are those that originate or occur in a hospital if they first appear 48 hours or more after admission or hospital-like settings.</p>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>The patient was a 40-year-old male admitted for chronic cough and a 2-month history of intermittent afternoon fever. He denied both a history of traveling and contact with animals over the previous 3 months. Associated symptoms included general malaise, anorexia, and the loss of 6 kg body weight within the previous 2 months. On admission, the vital signs were shown as blood pressure: 124/68 mmHg; pulse rate: 80/min; respiratory rate: 22/min; body temperature: 38.5&#xB0;C. Physical examination revealed a pansystolic murmur over the apex and left lower sternal border. An abscess in a molar cavity that required debridement was found, although the patient had not complained of dental pain. Laboratory tests revealed a WBC count of 9250/&#x3BC;L with elevated neutrophils (82.7%); normocytic anemia with a hemoglobin level of 10.4 g/dL; an elevated ESR level (123 mm/1 hr); and abnormal liver function with AST/ALT of 49/79 IU/L. A chest x-ray film revealed increased infiltration over the right upper and lower lobes, and abdominal sonography showed mild splenomegaly. Diagnosis of pulmonary tuberculosis was excluded by negative results from serial acid-fast stain and culture of <italic>Mycobacterium tuberculosis</italic>. Transthoracic echocardiography revealed a vegetation with size of 0.9 cm over the anterior leaflet of mitral valve, and moderate mitral regurgitation. However, the cardiac systolic and diastolic functions were normal with the ejection fraction of 78.9%, fraction shortening of 47.8%. Ultimately, definite subacute endocarditis was diagnosed according to the Duke criteria, including two blood culture results of <italic>B. vesicularis</italic>; the presence of vegetation on the mitral valve revealed by an echocardiogram (Fig. <xref ref-type="fig" rid="F1">1</xref>); and such clinical and laboratory features as fever, splenomegaly, heart murmur, anemia, Osler's node (Fig. <xref ref-type="fig" rid="F2">2</xref>),,and Roth's spot (Fig. <xref ref-type="fig" rid="F3">3</xref>).</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>Transthoracic echocardiogram showing vegetation (0.9 cm) over the anterior leaflet of mitral valve.</p>
        </caption>
        <graphic xlink:href="1471-2334-6-179-1"/>
      </fig>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p>Osler's node on the fourth digit of the left hand.</p>
        </caption>
        <graphic xlink:href="1471-2334-6-179-2"/>
      </fig>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p>Roth's spot on the retina of the left eye.</p>
        </caption>
        <graphic xlink:href="1471-2334-6-179-3"/>
      </fig>
      <p>The pathogen was identified as <italic>B. vesicularis </italic>on the basis of the biochemical characteristics tested by the API ID 32 GN automatic identification system (bioM&#xE9;rieux, Marcy I' &#xC9;toile, France). These included the characteristics of positive activity of D-maltose/D-glucose oxidation; negative activity of inositol/D-sorbitol/L-arabinose oxidation; negative activity of L-alanine/capric acid/potassium 5-ketogluconate/trisodium citrate decarboxylation; negative activity of nitrate reduction and indole production. The organism was susceptible to amikacin, gentamicin, piperacillin, aztreonam, cefepime, meropenem, netilmicin, ampicillin, amoxicillin, ciprofloxacin, cefazolin, cefmetazole, ceftazidime, cefotaxime, ceftriaxone, and ticarcillin, according to the susceptibility test performed by the disc diffusion method with interpretation criteria for <italic>Pseudomonas </italic>[<xref ref-type="bibr" rid="B16">16</xref>]. The patient was treated with a combination of cefazolin (2 gm/8 hr) and gentamicin (80 mg/8 hr) as empiric antibiotics during the first 3 days and fever subsided gradually.</p>
      <p>Ampicillin/sulbactam (3 gm/6 hr) was used alternatively for covering the infection of oral anaerobes while the patient underwent removal of the abscessed tooth. Treatment with amipicillin/sulbactam failed, however; the patient developed a flare-up of fever, the appearance of a new Osler's node on the fourth digit of the left hand (Fig. <xref ref-type="fig" rid="F2">2</xref>), and pain in the right femur with right inguinal lymphadenopathy. Treatment with a combination of ceftriaxone (2 gm/12 hr) and gentamicin (80 mg/8 hr) was administered subsequently. The femoral-inguinal symptoms and fever improved gradually with the antimicrobial therapy and therefore were ascribed to embolism. Although the clinical symptoms and signs improved after use of these antibiotics, ciprofloxacin (400 mg/12 hr) was administered as an alternative due to the eruption of a skin rash from an allergic reaction after 7 days' treatment with ceftriaxone. Ultimately, the patient received the treatment regimen for one month and was discharged. There were no sequelae at 6-month follow-up and the mitral vegetation disappeared in the follow-up echocardiogram performed one month after discharge.</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>Subacute infective endocarditis commonly involves heart valves already damaged in some way and is most often caused by one of the <italic>Viridans streptococci</italic>, such as <italic>Streptococcus sanguis</italic>, <italic>S. mutans</italic>, <italic>S. mitis</italic>, or <italic>S. milleri</italic>, which normally live in the mouth and throat. To the best of our knowledge, this is the first presentation of <italic>B. vesicularis </italic>manifesting as subacute endocarditis of the native valve. The dental cavity, which was the only infective focus noted, was proposed to be the origin of the infection even though no direct evidence of <italic>Brevundimonas </italic>was isolated from the dental abscess. <italic>B. vesicularis </italic>has been isolated from pus culture with tonsil swabs [<xref ref-type="bibr" rid="B13">13</xref>], suggesting the existence of the pathogen in the oral cavity. Furthermore, in the cases of tonsillitis and septic arthritis, the subjects had been immunocompetent before the occurrence of <italic>Brevundimonas </italic>infection [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Therefore, the clinical significance of the pathogen should not be confined solely to infections in immunocompromised hosts.</p>
      <p>According to researchers at the CDC, <italic>B. vesicularis </italic>is highly sensitive to all aminoglycosides (98%), piperacillin (100%), carbenicillin (94%), and ceftizoxime (94%), with moderate susceptibility to cefamandole (50%) and cefoxitin (75%), and lower susceptibility to penicillin (12%) and ampicillin (22%) [<xref ref-type="bibr" rid="B17">17</xref>]. The antibiograms of isolates from clinical cases were variable, however; most were determined by the disc diffusion method [[<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B13">13</xref>], Table <xref ref-type="table" rid="T2">2</xref>]. Our reported case was treated with cefazolin and gentamicin as empiric antibiotics initially, followed by amipicllin/sulbactam, then ceftriaxone and gentamicin, followed with ciprofloxacin. The failed clinical response in our case to ampicillin/sulbactam therapy even though susceptibility testing has demonstrated that the organism is susceptible to ampicillin/sulbactam, indicates that results from the disc diffusion method with reference to <italic>Pseudomonas </italic>species are not suitable in guiding antimicrobial therapy for <italic>B. vesicularis </italic>endocarditis. For endocarditis, minimum inhibitory concentration (MIC), minimum bactericidal concentration and serum bactericidal titer determination are appropriate to guide antimicrobial therapy. Our report has the limitation of lacking MIC determination as the antimicrobial susceptibility testing method. It is difficult to decide on the best antimicrobial for invasive infection due to <italic>B. vesicularis </italic>because of the low number of reported cases in humans caused by this pathogen; the fact that isolates come from various countries or findings from different laboratories; and the lack of standarized testing. Five of the reported cases [[<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B14">14</xref>], Table <xref ref-type="table" rid="T1">1</xref>] were successfully treated with a second- or third-generation cephalosporin with or without an aminoglycoside; two cases were treated with a &#x3B2;-lactam/&#x3B2;-lactamase inhibitor [[<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B13">13</xref>], Table <xref ref-type="table" rid="T1">1</xref>]; Two cases were treated with ciprofloxacin alone or combined with a monobactam [current case, [<xref ref-type="bibr" rid="B15">15</xref>], Table <xref ref-type="table" rid="T1">1</xref>]. Our experience in this case and previous cases of bacteremia suggest that a third-generation cephalosporin, piperacillin/tazobactam, aztreonam and ciprofloxacin are effective in treating infection due to <italic>B. vesicularis</italic>. Though subacute bacterial endocarditis caused by <italic>Pseudomonas </italic>spp. should be appropriately treated for 6 weeks [<xref ref-type="bibr" rid="B18">18</xref>], our reported case was successfully treated with four-week antimicrobial therapy. To decide the optimal duration of therapy for <italic>B. vesicularis </italic>endocarditis, more experience with such case is required.</p>
      <table-wrap position="float" id="T2">
        <label>Table 2</label>
        <caption>
          <p>In-vitro antibiotic susceptibility of <italic>Brevundimonas vesicularis</italic></p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td align="left">
                <bold>Reference</bold>
              </td>
              <td align="center">
                <bold>Current Case*</bold>
              </td>
              <td align="center">
                <bold>Choi</bold>
                <sup># </sup>
                <bold>(15)</bold>
              </td>
              <td align="center">
                <bold>Sofer</bold>
                <sup># </sup>
                <bold>(14)</bold>
              </td>
              <td align="center">
                <bold>Chi* (13)</bold>
              </td>
              <td align="center">
                <bold>Gilad* (9)</bold>
              </td>
              <td align="center">
                <bold>Oberhelman&#x2021; (10)</bold>
              </td>
              <td align="center">
                <bold>Planes* (8)</bold>
              </td>
            </tr>
            <tr>
              <td align="left">
                <bold>Year</bold>
              </td>
              <td align="center">
                <bold>2006</bold>
              </td>
              <td align="center">
                <bold>2006</bold>
              </td>
              <td align="center">
                <bold>2006</bold>
              </td>
              <td align="center">
                <bold>2004</bold>
              </td>
              <td align="center">
                <bold>2000</bold>
              </td>
              <td align="center">
                <bold>1994</bold>
              </td>
              <td align="center">
                <bold>1992</bold>
              </td>
            </tr>
            <tr>
              <td align="left">
                <bold>Antibiotics</bold>
              </td>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Ampicillin</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">R</td>
              <td align="center">R</td>
              <td align="center">N</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Piperacillin</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">R</td>
            </tr>
            <tr>
              <td align="left">Mezlocillin</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">N</td>
            </tr>
            <tr>
              <td align="left">Carbenicillin</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">N</td>
            </tr>
            <tr>
              <td align="left">Amoxicillin/clavulanate</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">N</td>
            </tr>
            <tr>
              <td align="left">Piperacillin/tazobactam</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">N</td>
            </tr>
            <tr>
              <td align="left">Cefazolin</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">R</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Cefuroxime</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">R</td>
              <td align="center">N</td>
              <td align="center">N</td>
            </tr>
            <tr>
              <td align="left">Cefoxitin</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Cefotaxime</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Ceftriaxone</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">R</td>
              <td align="center">S</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Ceftazidime</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">R</td>
              <td align="center">R</td>
              <td align="center">S</td>
              <td align="center">R</td>
            </tr>
            <tr>
              <td align="left">Gentamicin</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">R</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Tobramycin</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">R</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Amikacin</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Doxycycline</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Chloramphenicol</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">N</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Cotrimoxazole</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">S</td>
            </tr>
            <tr>
              <td align="left">Imipenem</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">N</td>
            </tr>
            <tr>
              <td align="left">Aztreonam</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">N</td>
              <td align="center">R</td>
              <td align="center">R</td>
              <td align="center">N</td>
              <td align="center">N</td>
            </tr>
            <tr>
              <td align="left">Ciprofloxacin</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">S</td>
              <td align="center">R</td>
              <td align="center">R</td>
              <td align="center">S</td>
              <td align="center">N</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>Abbreviations: S = susceptible; R = resistant; N = not determined</p>
          <p>* Susceptibility was determined by disc diffusion.</p>
          <p>&#x2021; Susceptibility was determined by automatic microdiffusion.</p>
          <p># Susceptibility was determined by an unknown method.</p>
        </table-wrap-foot>
      </table-wrap>
      <p>In conclusion, since cases of infection due to <italic>B. vesicularis </italic>are reported with increasing frequency, our endocarditis case report reinforces the hypothesis that bacteria can cause invasive disease in a person without predisposing disease. More treatment experience and more exact results from antimicrobial susceptibility testing are required to improve on present treatment regimens for invasive <italic>B. vesicularis </italic>infection.</p>
    </sec>
    <sec>
      <title>List of abbreviations</title>
      <p>ALT: alanine aminotransferase</p>
      <p>AST: aspartate aminotransferase</p>
      <p>CDC: Centers for Disease Control and Prevention, Atlanta, GA, U.S.A.</p>
      <p>ESR: erythrocyte sedimentation rate</p>
      <p>IU/L: international units per liter</p>
      <p>SLE: systemic lupus erythematosus</p>
      <p>WBC: white blood cell</p>
      <p>MIC: minimum inhibitory concentration</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author(s) declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>ML Yang and PL Lu took care the patient during hospitalization and prepared the manuscript. YH Chen, TC Chen, WR Lin and CY Lin participated in the the diagnosis and treatment of the disease. All authors read and approved the final version of the manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2334/6/179/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Gilligan</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Lum</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vandamme</surname>
              <given-names>PAR</given-names>
            </name>
            <name>
              <surname>Whittier</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH</surname>
            </name>
          </person-group>
          <article-title><italic>Burkholderia, Stenotrophomonas, Ralstonia, Brevundimonas, Comamonas, Delftia, Pandoraea </italic>and <italic>Acidovorax</italic></article-title>
          <source>Manual of Clinical Microbiology</source>
          <year>2003</year>
          <edition>8</edition>
          <publisher-name>Washington: American Society of Microbiology</publisher-name>
          <fpage>729</fpage>
          <lpage>748</lpage>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davis</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Boopathy</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Manning</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Use of trinitrobenzene as a nitrogen source by <italic>Pseudomonas vesicularis </italic>isolated from soil</article-title>
          <source>Curr Microbiol</source>
          <year>1997</year>
          <volume>34</volume>
          <fpage>192</fpage>
          <lpage>197</lpage>
          <pub-id pub-id-type="pmid">9009074</pub-id>
          <pub-id pub-id-type="doi">10.1007/s002849900167</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morais</surname>
              <given-names>PV</given-names>
            </name>
            <name>
              <surname>da Costa</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Alterations in the major heterotrophic bacterial populations isolated from a still bottled mineral water</article-title>
          <source>J Appl Bacteriol</source>
          <year>1990</year>
          <volume>69</volume>
          <fpage>750</fpage>
          <lpage>757</lpage>
          <pub-id pub-id-type="pmid">2276989</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koide</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miyata</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nukina</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Teramoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakanishi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kamiki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Umeda</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Nakai</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>A strain of <italic>Pseudomonas vesicularis </italic>isolated from shower hose which supports the multiplication of <italic>Legionella</italic></article-title>
          <source>Kansenshogaku Zasshi</source>
          <year>1989</year>
          <volume>63</volume>
          <fpage>1160</fpage>
          <lpage>1164</lpage>
          <pub-id pub-id-type="pmid">2614089</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aspinall</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Two sources of contamination of a hydrotherapy pool by environmental organisms</article-title>
          <source>J Hosp Infect</source>
          <year>1989</year>
          <volume>14</volume>
          <fpage>285</fpage>
          <lpage>292</lpage>
          <pub-id pub-id-type="pmid">2575627</pub-id>
          <pub-id pub-id-type="doi">10.1016/0195-6701(89)90068-6</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Otto</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Deboo</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Capers</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Pickett</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title><italic>Pseudomonas vesicularis </italic>from cervical specimens</article-title>
          <source>J Clin Microbiol</source>
          <year>1978</year>
          <volume>7</volume>
          <fpage>341</fpage>
          <lpage>345</lpage>
          <pub-id pub-id-type="pmid">567655</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Segers</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Vancanneyt</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pot</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Torck</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Hoste</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dewettinck</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Falsen</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kersters</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>De Vos</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Classification of <italic>Pseudomonas diminuta </italic>Leifson and Hugh 1954 and <italic>Pseudomonas vesicularis </italic>B&#xFC;sing, D&#xF6;ll, and Freytag 1953 in <italic>Brevundimonas </italic>gen. nov. as <italic>Brevundimonas diminuta </italic>comb. nov. and <italic>Brevundimonas vesicularis </italic>comb. nov., respectively</article-title>
          <source>Int J Syst Bacteriol</source>
          <year>1994</year>
          <volume>44</volume>
          <fpage>499</fpage>
          <lpage>510</lpage>
          <pub-id pub-id-type="pmid">8068543</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Planes</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Ramirez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fernandez</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Capdevila</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Tolosa</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title><italic>Pseudomonas vesicularis </italic>bacteraemia</article-title>
          <source>Infection</source>
          <year>1992</year>
          <volume>20</volume>
          <fpage>367</fpage>
          <lpage>368</lpage>
          <pub-id pub-id-type="pmid">1293060</pub-id>
          <pub-id pub-id-type="doi">10.1007/BF01710687</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gilad</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Borer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Peled</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Riesenberg</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tager</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Appelbaum</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schlaffer</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Hospital-acquired <italic>Brevundimonas vesicularis </italic>septicaemia following open-heart surgery: case report and literature review</article-title>
          <source>Scand J Infect Dis</source>
          <year>2000</year>
          <volume>32</volume>
          <fpage>90</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">10716085</pub-id>
          <pub-id pub-id-type="doi">10.1080/00365540050164290</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oberhelman</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Humbert</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Santorelli</surname>
              <given-names>FW</given-names>
            </name>
          </person-group>
          <article-title><italic>Pseudomonas vesicularis </italic>causing bacteremia in a child with sickle cell anemia</article-title>
          <source>South Med J</source>
          <year>1994</year>
          <volume>87</volume>
          <fpage>821</fpage>
          <lpage>822</lpage>
          <pub-id pub-id-type="pmid">8052892</pub-id>
          <pub-id pub-id-type="doi">10.1097/00007611-199408000-00012</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vanholder</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Vanhaecke</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ringoir</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title><italic>Pseudomonas </italic>septicemia due to deficient disinfectant mixing during reuse</article-title>
          <source>Int J Artif Organs</source>
          <year>1992</year>
          <volume>15</volume>
          <fpage>19</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">1551723</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Calegari</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gezuele</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Torres</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Carmona</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Botryomycosis caused by <italic>Pseudomonas vesicularis</italic></article-title>
          <source>Int J Dermatol</source>
          <year>1996</year>
          <volume>35</volume>
          <fpage>817</fpage>
          <lpage>818</lpage>
          <pub-id pub-id-type="pmid">8915740</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chi</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Fung</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>CY</given-names>
            </name>
          </person-group>
          <article-title><italic>Brevundimonas </italic>bacteremia: two case reports and literature review</article-title>
          <source>Scan J Infect Dis</source>
          <year>2004</year>
          <volume>36</volume>
          <fpage>59</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="doi">10.1080/00365540310018879</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sofer</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zmira</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Amir</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Brevundimonas vesicularis septic arthritis in an immunocompetent child</article-title>
          <source>Eur J Pediatr</source>
          <year>2007</year>
          <volume>166</volume>
          <fpage>77</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="pmid">16941131</pub-id>
          <pub-id pub-id-type="doi">10.1007/s00431-006-0216-y</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choi</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Seo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pyo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>YJ</given-names>
            </name>
          </person-group>
          <article-title>CAPD peritonitis due to Brevundimonas vesicularis</article-title>
          <source>Perit Dial Int</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>510</fpage>
          <lpage>512</lpage>
          <pub-id pub-id-type="pmid">16881352</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <collab>Clinical and Laboratory Standards Institute/National Committee for Clinical Laboratory Standards</collab>
          </person-group>
          <article-title>Performance standards for antimicrobial disc susceptibility tests. Approved standard, M2-A9, 9th edition</article-title>
          <source>National Committee for Clinical Laboratory Standards, Wayne Pa</source>
          <year>2006</year>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Clark</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Hollis</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Weaver</surname>
              <given-names>RE</given-names>
            </name>
            <collab>(Eds)</collab>
          </person-group>
          <article-title>Identification of unusual pathologic gram-negative aerobic and facultatively anaerobic bacteria</article-title>
          <source>Department of Health and Human Services, Centers for Disease Control, Atlanta, US</source>
          <year>1984</year>
          <fpage>286</fpage>
          <lpage>287</lpage>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baddour</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Bayer</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Fowler</surname>
              <given-names>VG</given-names>
            </name>
            <name>
              <surname>Bolger</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Levison</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Ferrieri</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gerber</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Tani</surname>
              <given-names>LY</given-names>
            </name>
            <name>
              <surname>Gewitz</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Tong</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Steckelberg</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Baltimore</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Shulman</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Burns</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Falace</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Newburger</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Pallasch</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Taubert</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America</article-title>
          <source>Circulation</source>
          <year>2005</year>
          <volume>111</volume>
          <fpage>e394</fpage>
          <lpage>e434</lpage>
          <pub-id pub-id-type="pmid">15956145</pub-id>
          <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.165564</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
